Similar to our findings, studies have demonstrated that autophagy in PD dopaminergic cells was regulated by the AMPK/mTOR signaling pathway, suggesting that AMPK/mTOR-mediated autophagy may also be a potential therapeutic target for the treatment of PD patients (Ng et al., 2012). Here, MTOR is linked to Parkinson disease.